Avantor, Inc. $AVTR Shares Bought by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC grew its stake in Avantor, Inc. (NYSE:AVTR) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,105,065 shares of the company’s stock after buying an additional 84,740 shares during the quarter. Avantor accounts for about 4.0% of Clarkston Capital Partners LLC’s investment portfolio, making the stock its 4th biggest holding. Clarkston Capital Partners LLC owned about 2.22% of Avantor worth $173,104,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its position in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new position in Avantor during the second quarter worth $32,000. Private Trust Co. NA boosted its holdings in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares during the last quarter. Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in Avantor during the fourth quarter worth $32,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analysts Set New Price Targets

AVTR has been the subject of several recent research reports. Wells Fargo & Company reduced their target price on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a report on Friday, February 13th. Citigroup reduced their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Morgan Stanley set a $10.00 target price on shares of Avantor in a report on Friday, February 13th. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Finally, Barclays reduced their target price on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $10.57.

Avantor Stock Performance

Shares of AVTR stock opened at $9.38 on Friday. The stock has a market cap of $6.40 billion, a P/E ratio of -11.57, a P/E/G ratio of 5.60 and a beta of 0.97. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The company has a fifty day moving average price of $8.38 and a two-hundred day moving average price of $9.63. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the company posted $0.23 earnings per share. As a group, equities analysts predict that Avantor, Inc. will post 0.79 EPS for the current year.

Insiders Place Their Bets

In other news, Director Simon Dingemans purchased 25,000 shares of the business’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the purchase, the director directly owned 25,000 shares in the company, valued at $203,500. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gregory T. Lucier purchased 10,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director owned 60,000 shares of the company’s stock, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.28% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.